XOLREMDI

Serial Number 90476808
Registration 7489281
700

Registration Progress

Application Filed
Jan 20, 2021
Under Examination
Nov 2, 2021
Approved for Publication
Sep 7, 2021
Published for Opposition
Sep 7, 2021
Registered
Aug 27, 2024

Basic Information

Serial Number
90476808
Registration Number
7489281
Filing Date
January 20, 2021
Registration Date
August 27, 2024
Published for Opposition
September 7, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 27, 2024
Registration
Registered
Classes
005

Rights Holder

X4 Pharmaceuticals, Inc.

03
Address
61 North Beacon Street, 4th Floor
Boston, MA 02134

Ownership History

X4 Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

X4 Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

X4 Pharmaceuticals, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Glenn A. Gundersen

USPTO Deadlines

Next Deadline
1875 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-27)
Due Date
August 27, 2030
Grace Period Ends
February 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description
Oct 23, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 23, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 23, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 27, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 27, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 20, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 20, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 16, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 14, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 3, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 3, 2024 IUAF S USE AMENDMENT FILED
May 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2024 EXT5 S SOU EXTENSION 5 FILED
Apr 30, 2024 EX5G S SOU EXTENSION 5 GRANTED
Apr 30, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 31, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2023 EX4G S SOU EXTENSION 4 GRANTED
Oct 28, 2023 EXT4 S SOU EXTENSION 4 FILED
Oct 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
May 2, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 30, 2023 EX3G S SOU EXTENSION 3 GRANTED
Apr 30, 2023 EXT3 S SOU EXTENSION 3 FILED
Nov 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2022 EX2G S SOU EXTENSION 2 GRANTED
Oct 31, 2022 EXT2 S SOU EXTENSION 2 FILED
Oct 31, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 31, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 31, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 31, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 31, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 3, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2022 EX1G S SOU EXTENSION 1 GRANTED
Apr 29, 2022 EXT1 S SOU EXTENSION 1 FILED
Apr 29, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 2, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 7, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 7, 2021 PUBO A PUBLISHED FOR OPPOSITION
Aug 18, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 4, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2021 DOCK D ASSIGNED TO EXAMINER
Apr 21, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for the treatment of immunodeficiencies; Pharmaceutical preparations for the treatment of neutropenia
First Use Anywhere: 20240500
First Use in Commerce: 20240500

Classification

International Classes
005